We are live on ! Find out more
AMBI

Ambit Biosciences Corp
AMBI

Delisted

AMBI was delisted on the 10th of November, 2014.

Back to rankings

0 hedge funds and large institutions have $0 invested in Ambit Biosciences Corp in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 49 → 0 (-49)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $154M → $0 (-$154M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 48

Holders
–
Holders Change
-49
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management I
California
-$32M
2
AC
Aisling Capital
New York
-$25.4M
3
O
OrbiMed
New York
-$23M
4
BBA
Baker Bros. Advisors
New York
-$16.8M
5
GPP
Great Point Partners
Connecticut
-$9.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
– -$533K -34,600 Closed
O
27
OppenheimerFunds
New York
– -$522K -33,915 Closed
RIL
28
Rothschild Investment LLC
Illinois
– -$472K -30,630 Closed
BFA
29
BlackRock Fund Advisors
California
– -$388K -25,213 Closed
LOAMU
30
Lombard Odier Asset Management (USA)
New York
– -$385K -25,000 Closed
CL
31
CSS LLC
Illinois
– -$379K -24,622 Closed
Bank of New York Mellon
32
Bank of New York Mellon
New York
– -$369K -23,955 Closed
JG
33
Jefferies Group
New York
– -$354K -23,000 Closed
OAC
34
OMERS Administration Corp
Ontario, Canada
– -$331K -21,500 Closed
Northern Trust
35
Northern Trust
Illinois
– -$301K -19,525 Closed
N
36
Natixis
France
– -$241K -15,663 Closed
PCM
37
Prelude Capital Management
New York
– -$77K -5,000 Closed
Ameriprise
38
Ameriprise
Minnesota
– -$49K -3,196 Closed
FNYS
39
First New York Securities
New York
– -$46.2K -3,000 Closed
BA
40
BlackRock Advisors
Delaware
– -$33K -2,150 Closed
BIM
41
BlackRock Investment Management
Delaware
– -$31K -2,011 Closed
Bank of America
42
Bank of America
North Carolina
– -$15K -955 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$8K -516 Closed
MTIP
44
Magee Thomson Investment Partners
California
– -$7K -426 Closed
Citigroup
45
Citigroup
New York
– -$6K -367 Closed
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3 -178 Closed
LTFS
47
Ladenburg Thalmann Financial Services
Florida
– -$1K -50 Closed
1
2

AMBI Hedge Fund Activity: Q4 2014 in Review

0 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q4 2014, worth a combined $0 — down 100% from $154M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of AMBI and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Foresite Capital Management I, exiting entirely with an estimated $32M sold.

  • 0 institutional investors held Ambit Biosciences Corp (AMBI) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $0 of Ambit Biosciences Corp stock for Q4 2014, down 100% quarter-over-quarter.
  • 0 funds opened new Ambit Biosciences Corp positions in Q4 2014 and 48 closed out, a net change of -48 holders.
  • The largest Ambit Biosciences Corp seller in Q4 2014 was Foresite Capital Management I, an estimated $32M sold.

Based on aggregated 13F filings for Q4 2014.